803 filings
Page 23 of 41
CORRESP
TGTX
TG Therapeutics Inc
14 Jun 13
Correspondence with SEC
12:00am
CT ORDER
TGTX
TG Therapeutics Inc
12 Jun 13
Confidential treatment order
12:00am
10-K/A
2012 FY
TGTX
TG Therapeutics Inc
Annual report (amended)
10 Jun 13
12:00am
8-K
TGTX
TG Therapeutics Inc
6 Jun 13
Submission of Matters to a Vote of Security Holders
12:00am
UPLOAD
TGTX
TG Therapeutics Inc
6 Jun 13
Letter from SEC
12:00am
8-K
TGTX
TG Therapeutics Inc
3 Jun 13
40% of Rituximab-Refractory Patients (2/5) Achieve a Complete Response
12:00am
S-3
TGTX
TG Therapeutics Inc
Shelf registration
31 May 13
12:00am
8-K
TGTX
TG Therapeutics Inc
28 May 13
TG Therapeutics, Inc. Approved for Listing on the Nasdaq Capital Market
12:00am
8-A12B
TGTX
TG Therapeutics Inc
28 May 13
Registration of securities on exchange
12:00am
8-K
TGTX
TG Therapeutics Inc
14 May 13
TG Therapeutics, Inc. Announces First Quarter 2013 Financial Results and Business Update
12:00am
10-Q
2013 Q1
TGTX
TG Therapeutics Inc
Quarterly report
14 May 13
12:00am
DEF 14A
TGTX
TG Therapeutics Inc
Definitive proxy
24 Apr 13
12:00am
10-K
2012 FY
TGTX
TG Therapeutics Inc
Annual report
21 Mar 13
12:00am
8-K
TGTX
TG Therapeutics Inc
12 Mar 13
TG Therapeutics, Inc. Announces Fourth Quarter and Year-End 2012 Financial Results and Business Update
12:00am
8-K
TGTX
TG Therapeutics Inc
25 Feb 13
Regulation FD Disclosure
12:00am
CT ORDER
TGTX
TG Therapeutics Inc
8 Feb 13
Confidential treatment order
12:00am
8-K
TGTX
TG Therapeutics Inc
22 Jan 13
Shareholder Nominations Pursuant to Exchange Act Rule 14a-11
12:00am
8-K
TGTX
TG Therapeutics Inc
3 Jan 13
Departure of Directors or Certain Officers
12:00am
8-K
TGTX
TG Therapeutics Inc
10 Dec 12
Dr. Owen O’Connor Presents Early Clinical Data on the Safety and Efficacy from two Ongoing Phase I Trials of TG-1101
12:00am
8-K
TGTX
TG Therapeutics Inc
15 Nov 12
Entry into a Material Definitive Agreement
12:00am